tradingkey.logo
tradingkey.logo
Search

Biogen - Expects Q1 2026 GAAP And Non-GAAP EPS Impact Of $0.19 From Charge - SEC Filing

ReutersApr 6, 2026 10:51 AM

- Biogen Inc BIIB.O:

  • BIOGEN - EXPECTS Q1 2026 GAAP AND NON-GAAP EPS IMPACT OF $0.19 FROM CHARGE - SEC FILING

  • BIOGEN - EXPECTS Q1 2026 $34 MILLION BOUGHT IN-PROCESS RESEARCH AND DEVELOPMENT, UPFRONT AND MILESTONE EXPENSE - SEC FILING

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI